46 results
6-K
EX-1.1
IPHA
Innate Pharma
6 Feb 24
Current report (foreign)
5:05pm
, employees or any other party, (iii) the Agent has not assumed nor will assume an advisory or fiduciary responsibility in favor of the Company
424B5
IPHA
Innate Pharma
6 Feb 24
Prospectus supplement for primary offering
5:00pm
to which we have referred you. We take no responsibility for, and provide no assurances as to the reliability of, any other information that others may … , managing director, member of the Executive Board or of the Supervisory
S-20
Board, or, in a general manner is in a position of responsibility within
6-K
aau8x qa3830pg4
5 Jan 24
Innate Pharma S.a. 6-K
6:09am
6-K
EX-99.1
lj6f 280og4cr59
4 Jan 24
Innate Pharma 6-K
6:00am
F-3
wvgb84
20 Dec 23
Shelf registration (foreign)
4:45pm
6-K
EX-99.2
syxnmfd52
14 Sep 23
Innate Pharma Reports First Half 2023 Financial Results and Business Update
6:27am
6-K
EX-1.1
hkjvz2 z5s
26 Apr 23
Current report (foreign)
4:02pm
424B5
voqdsmb3
26 Apr 23
Prospectus supplement for primary offering
4:01pm
20-F/A
EX-4.9
46jdcd
20 Apr 23
Annual report (foreign) (amended)
8:47am
6-K
EX-99.1
fknvu swd
19 Dec 22
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.2
hf8f649 bh20at
15 Sep 22
Innate Pharma Reports First Half 2022 Financial Results and Business Update
6:12am
6-K
EX-1.1
6868jrdem
3 May 22
Current report (foreign)
5:08pm
424B5
td249hzuna3g6 aho
3 May 22
Prospectus supplement for primary offering
4:36pm
6-K
EX-99.2
7qu02o wsh4kl2rm
15 Sep 21
Innate Pharma Reports First Half 2021 Financial Results and Business Update
6:07am